Evidence map›Paper›PMID 22491230›Full record

ArticleJournal of the National Cancer Institute2012

Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS.

Larissa Nekhlyudov, Laurel A Habel, Ninah Achacoso, Inkyung Jung, Reina Haque, Laura C Collins, Stuart J Schnitt, Charles P Quesenberry, Suzanne W Fletcher

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of the National Cancer Institute, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us?International journal of molecular sciences · 2023
    Review
  2. The OncoSim-Breast Cancer Microsimulation Model.Current oncology (Toronto, Ont.) · 2022
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Larissa NekhlyudovDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Ave, 6th Floor, Boston, MA 02215, USA. larissa_nekhlyudov@harvardpilgrim.org
Laurel A Habel
Ninah Achacoso
Inkyung Jung
Reina Haque
Laura C Collins
Stuart J Schnitt
Charles P Quesenberry
Suzanne W Fletcher
Beth Israel Deaconess Medical Center · USHarvard Pilgrim Health Care · USYonsei University · KRHarvard University · USHarvard Vanguard Medical Associates · USKaiser Permanente · US

Funding

The HMO Cancer Research Network (CRN)U19CA079689 · NCI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI WAGNER, EDWARD H · 1999 to 2011
$62.6M
DCIS--MAMMOGRAPHIC FEATURES AND PROGNOSISR01CA081302 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI HABEL, LAUREL A · 1999 to 2003
$1.1M
NCI NIH HHS R01CA81302NCI NIH HHS U19CA79689
6 · The paper itself

Abstract

backgroundBreast-conserving surgery (BCS) is the most common treatment for ductal carcinoma in situ (DCIS); however, how often women experience subsequent diagnostic evaluations over time is not known.

methodsWe identified 2948 women with DCIS who were treated with BCS from 1990 to 2001 and followed for up to 10 years at three integrated health-care delivery systems. We calculated the percentages of diagnostic mammograms and ipsilateral invasive procedures following the initial breast excision to treat DCIS, estimated the 10-year cumulative incidence of these procedures, and determined hazard ratios for both types of procedures with Cox regression modeling. All statistical tests were two-sided.

resultsOver 10 years, 907 women (30.8%) had 1422 diagnostic mammograms and 1813 (61.5%) had 2305 ipsilateral invasive procedures. Diagnostic mammograms occurred in 7.3% of women in the first 6 months and continued at a median annual rate of 4.3%. Ipsilateral invasive procedures occurred in 51.5% of women in the first 6 months and continued at a median annual rate of 3.1%. The estimated 10-year cumulative risk of having at least one diagnostic mammogram after initial DCIS excision was 41.0% (95% confidence interval [CI] = 38.5% to 43.5%); at least one invasive procedure, 65.7% (95% CI = 63.7% to 67.8%); and either event, 76.1% (95% CI = 74.1% to 78.1%). Excluding events in the first 6 months following initial DCIS excision, corresponding risks were 36.4% (95% CI = 33.8% to 39.0%) for diagnostic mammograms, 30.4% (95% CI = 26.9% to 33.8%) for invasive procedures, and 49.5% (95% CI = 45.6% to 53.5%) for either event.

conclusionsWomen with DCIS treated with BCS continue to have diagnostic and invasive breast procedures in the conserved breast over an extended period. The frequency of ongoing diagnostic breast evaluations should be included in discussions about treatment.

Indexed as

Mastectomy, SegmentalAdultAgedAged, 80 and overBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingDelivery of Health Care, IntegratedEarly Detection of CancerFemaleFollow-Up StudiesHumansIncidenceMammographyMiddle AgedNeoplasm Recurrence, LocalPatient Selection

Identifiers

PMID22491230
PMCPMC3328423
OpenAlexW2096634613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.